Search results for "LIX"

showing 10 items of 891 documents

MINIMIZING INFLIXIMAB TOXICITY IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

2008

Abstract Background Infliximab is a widely used biological agent for the treatment of inflammatory bowel disease, and has a favorable risk/benefit ratio. Aim It is useful to know that patients treated with infliximab are exposed to developing adverse events that could be reduced with a prudent and a rational clinical approach and by optimizing the treatment protocol. Methods PubMed (including Epub) was searched in October 2006 and again in March 2007. Results The high immunogenic potential of infliximab determines the antibodies that inhibit the effect of infliximab and the appearance of subsequent acute and delayed infusion reactions. Infliximab has an immunomodulatory effect, thus increas…

musculoskeletal diseasesmedicine.medical_specialtyTuberculosisInflammatory bowel diseaseGastroenterologyDrug Administration SchedulePharmacotherapyimmune system diseasesInternal medicinemedicineHumansImmunologic Factorsskin and connective tissue diseasesAdverse effectClinical Trials as TopicHepatologybusiness.industryTumor Necrosis Factor-alphaGastroenterologyAntibodies Monoclonalmedicine.diseaseInflammatory Bowel DiseasesInfliximabInfliximabLymphomastomatognathic diseasesHeart failureToxicityDrug Therapy CombinationbusinessImmunosuppressive Agentsmedicine.drug
researchProduct

Levetiracetam‐induced pediatric toxic epidermal necrolysis successfully treated with etanercept

2020

Successful management of toxic epidermal necrolysis (TEN) with tumor necrosis factor-α inhibitors has been described in adults, but few cases have been reported in children. To date, only four pediatric cases of TEN treated with infliximab and one with etanercept have been published. We present the case of an 8-year-old boy diagnosed with TEN induced by levetiracetam, successfully treated with etanercept, systemic corticosteroids, and intravenous immunoglobulin.

musculoskeletal diseasesmedicine.medical_specialtybiologybusiness.industryDermatologymedicine.diseaseDermatologyToxic epidermal necrolysisInfliximabEtanercept030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisPediatrics Perinatology and Child Healthbiology.proteinmedicineTumor necrosis factor alphaLevetiracetamAntibodyskin and connective tissue diseasesbusinessmedicine.drugPediatric Dermatology
researchProduct

Honeybees affect floral microbiome composition in a central food source for wild pollinators in boreal ecosystems

2021

AbstractBasic knowledge on dispersal of microbes in pollinator networks is essential for plant, insect, and microbial ecology. Thorough understanding of the ecological consequences of honeybee farming on these complex plant–pollinator–microbe interactions is a prerequisite for sustainable honeybee keeping. Most research on plant–pollinator–microbe interactions have focused on temperate agricultural systems. Therefore, information on a wild plant that is a seasonal bottleneck for pollinators in cold climate such as Salix phylicifolia is of specific importance. We investigated how floral visitation by insects influences the community structure of bacteria and fungi in Salix phylicifolia inflo…

pajutsalix phylicifoliapölytysbakteeritkukinnotmehiläishoitohyönteisetinflorescencefungibacteriapölyttäjättarhamehiläinensienetsiitepölyEcology Evolution Behavior and Systematicsrichness
researchProduct

Kapitalismin käsite : Deleuzen ja Guattarin Marx-luenta ja autonomiset liikkeet

2014

Tutkielmassa lähestytään kapitalismin käsitettä Gilles Deleuzen ja Félix Guattarin Marx-luennan pohjalta. Pyrin muodostamaan systemaattisen esityksen Deleuzen ja Guattarin kapitalismianalyysista, joka on toiminut yhtenä viitekehyksenä 1990-luvulla nousseelle tietotalous- ja prekariaattikeskustelulle sekä tietyille yhteiskunnallisille liikkeille, kuten EuroMayDay-mielenosoituksia järjestäneelle ja perustuloa vaatineelle prekariaattiliikkeelle. Deleuzen ja Guattarin ajattelussa kapitalismi on yhteiskunnallisten virtausten sattumanvaraisesta yhdistymisestä kehittynyt monimutkainen ja globaali yhteiskuntajärjestelmä, joka elää ristiriidoista ja jonka ainoa tarkoitus on Marxin esittelemän pääoma…

prekariaattikapitalismiDeleuze GillesMarx KarlyhteiskuntasubjektiviteettitalousjärjestelmätGuattari Félix
researchProduct

Semʹâ i vospitanie detejv religioznom diskurse arhiepiskopa Simferopolʹskogo i Krymskogo Luki

2020

During four decades of his service in the Church, Valentin Felixovich Voino-Yasenetsky (Archbishop Luke of Simferopol and Crimea) delivered numerous sermons, most of which were recorded. Later, they began to appear in the form of publications and became the object of research by representatives of various scientific disciplines. In his sermons, apart from other issues, the preacher paid special attention to the family and education of the younger generation. This article is an attempt to analyze the religious discourse of the Archbishop,using the example of the sermon “On the family and education of children”, delivered by him on 13 October 1947. The author of the sermon adheres to the trad…

religious discourseValentin Felixovich Voino-Yasenetskyeducationtheolinguistic approachfamilylinguistic meansArchbishop LukesermonStylistyka
researchProduct

Effects of temperature rising and ocean acidification on reproductive success in the sea urchin Arbacia lixula (L.)

2011

reproductionSettore BIO/07 - EcologiaacidificationArbacia lixula
researchProduct

CCDC 1524101: Experimental Crystal Structure Determination

2017

UCUZOK : 6,12,18,24-tetramethoxy-2,8,14,20-tetranonyl-4,10,16,22-tetrahydroxycalix[4]arene propan-2-ol solvate Space Group: P-1, Cell: a 12.27090(10)Å b 13.96500(10)Å c 19.53620(10)Å, α 83.2880(1)° β 89.0250(1)° γ 84.9650(1)° Work published 2017 via Cambridge Crystallographic Data Centre.

resorcinarenesolvatecalixarenemacrocyclesupramolecular chemistry
researchProduct

CCDC 264161: Experimental Crystal Structure Determination

2017

WEJVOZ : New structure undergoing enhancement. Space Group: P21/c, Cell: a 18.5217(4)Å b 23.2973(6)Å c 21.1118(3)Å, α 90.00° β 96.591(1)° γ 90.00°. Work published 2017 via Cambridge Crystallographic Data Centre.

resorcinarenesolvateoctapodandcalixarenemacrocyclesupramolecular chemistry
researchProduct

CCDC 750239: Experimental Crystal Structure Determination

2014

UDUXOI : 2,26,51,54-Tetraethyl-6,24,30,48-tetramethoxy-9,12,15,18,21,33,36,39,42,45-decaoxaheptacyclo[27.19.3.35,25.03,8.022,53.027,32.046,50]tetrapentaconta-1(48),3,5,7,22,24,27,29,31,46,49,52-dodecaene methanol solvate. Work published 2014 via Cambridge Crystallographic Data Centre.

resorcinarenesolvateresorcinarene-bis-crowncalixarenesupramolecular chemistry
researchProduct

Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-α blockers: The GI…

2007

OBJECTIVE: To assess the prevalence of good clinical response and remission in rheumatoid arthritis (RA) patients with longstanding disease treated with anti-tumor necrosis factor-alpha (TNF-alpha) drugs at outpatient clinics. METHODS: Retrospective national study of 14 academic tertiary referral rheumatology medical centers. RA patients with a Disease Activity Score (DAS28) > 3.2 were defined as having active disease and could start TNF-alpha blockers. All patients received one TNF-alpha blocker plus methotrexate (10-20 mg/wk). At the third month the patients were categorized as responders or nonresponders, based on improvement of at least 0.25 of the Health Assessment Questionnaire (HAQ).…

rheumatoid arthritisAdultMaleQuality Assurance Health Carepredictors of remissionTumor Necrosis Factor blockersAntibodies Monoclonal HumanizedSeverity of Illness IndexReceptors Tumor Necrosis FactorEtanerceptArthritis RheumatoidRheumatoid arthritis; Good clinical response; Tumor Necrosis Factor blockersPredictive Value of TestsHumansRheumatoid arthritispredictors of remission; rheumatoid arthritis; tumor necrosis factor-alpha blockersAgedRetrospective StudiesGood clinical responseTumor Necrosis Factor-alphatumor necrosis factor-alpha blockersRemission InductionAdalimumabAntibodies MonoclonalMiddle AgedPrognosisInfliximabLogistic ModelsMethotrexateTreatment Outcomedisability score; good clinical response; remission; rheumatoid arthritis; tumor necrosis factor-α blockersItalyAntirheumatic AgentsImmunoglobulin GFemale
researchProduct